Risk communication in cancer genetics: lay people's expectations and providers' practices (CRISCOM)

Grunddaten zu diesem Projekt

Art des ProjektesEU-Projekt koordiniert außerhalb der Universität Münster
Laufzeit an der Universität Münster01.10.2001 - 30.04.2003

Beschreibung

The heterogeneity of Cancer genetic clinics content is poorly documented at the European level, and no comparative data exist on the expectations and health priorities perceived both by lay people and by health care providers. The general objective of this proposal is to co-ordinate activities to prepare a European RTD project on lay people's expectations and on providers' practices on risk communication in cancer genetics in 8 European countries. The steps are first to design a study to compare the content of national cancer genetic clinics through standardised measurements and second to design and to cross-culturally validate two protocols and their measurement tools (questionnaires in every nation language). This will be carried out through panels that will work on specific objectives and meet to share their positions during 3 workshops.

Stichwörtercancer genetics; risk communication
FörderkennzeichenQLG7-CT-2001-30236
Mittelgeber / Förderformat
  • EU FP 5 - Research network contracts

Projektleitung der Universität Münster

Nippert, Irmgard
Klinik für Medizinische Genetik

Antragsteller*innen der Universität Münster

Nippert, Irmgard
Klinik für Medizinische Genetik

Projektbeteiligte Organisationen außerhalb der Universität Münster

  • Leiden University Medical Center (LUMC)Niederlande (Königreich der)
  • Institut National De La Sante Et De La Recherche Medicale (INSERM)Frankreich
  • University of ManchesterVereinigtes Königreich
  • St. Mary’s HospitalVereinigtes Königreich
  • Medizinische Hochschule Hannover (MHH)Deutschland
  • Technion - Israel Institute of TechnologyIsrael
  • Katholische Universität Leuven (KU Leuven)Belgien